A Clinical Trial of Epizon-701 (EPN-701) in Subjects With End-Stage Renal Disease (ESRD)
Condition(s):End-Stage Renal Disease (ESRD)Last Updated:March 18, 2022Completed
Hide Studies Not Open or Pending
Condition(s):End-Stage Renal Disease (ESRD)Last Updated:March 18, 2022Completed
Condition(s):Atrial FibrillationLast Updated:April 6, 2011Completed
Condition(s):Deep Vein Thrombosis; Pulmonary EmbolismLast Updated:March 19, 2021Completed
Condition(s):Severe Bleeding; Urgent SurgeryLast Updated:July 16, 2020Completed
Condition(s):Unsuspected Pulmonary EmbolismLast Updated:August 8, 2019Completed
Condition(s):Antiphospholipid Syndrome; Arterial ThrombosisLast Updated:December 14, 2022Recruiting
Condition(s):Venous Thromboembolism; NeoplasmsLast Updated:December 3, 2014Terminated
Condition(s):Severe Bleeding; Urgent SurgeryLast Updated:July 17, 2020Withdrawn
Condition(s):Kidney Calculi; Calcium Oxalate Kidney Stones; Vitamin K 2; Human; Kidney Stone; Calcium Oxalate Urolithiasis; Calcium Phosphate Urolithiasis; NephrolithiasisLast Updated:June 28, 2023Active, not recruiting
Condition(s):Vascular CalcificationLast Updated:January 31, 2017Unknown status
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.